Anatomical loci of HIV-associated immune activation and association with viraemia

Lancet

Volumn 362, Issue 9388, 2003, Pages 945-950

  Iyengar, Sujatha ^a   Chin, Bennett ^b   Margolick, Joseph B ^a   Sabundayo, Beulah P ^a   Schwartz, David H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18; INFLUENZA VACCINE;

ADULT; ARTICLE; AXILLARY LYMPH NODE; CERVICAL LYMPH NODE; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; GENE LOCUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFLUENZA; INFLUENZA VACCINATION; INJECTION; LICENSING; LINEAR REGRESSION ANALYSIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; SURGICAL APPROACH; TEACHING HOSPITAL; URBAN AREA; VIREMIA; VIRUS LOAD;

EID: 0141831931     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14363-2     Document Type: Article

References (32)

1. Kaur A, Barabasz AF, Rosenzweig M, McClure HM, Feinberg MB, Johnson RP. Dynamics of T-lymphocyte turnover in sooty mangabeys, a nonpathogenic host of simian immunodeficiency Virus Infection. 9th Conference on Retroviruses and Opportunistic Infections 2002 Seattle, WA, USA (abstr 22).
2. Silvestri G., Sodora D.L., Koup R.A., et al. Nonpathogenic SIV infection in sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viraemia. Immunity. 18:2003;441-452.
3. Mohri H., Perelson A.S., Tung K., et al. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J Exp Med. 194:2001;1277-1287.
4. Haase A.T. Population biology of HIV-1 infection: viral and CD4+ T cell demographics and dynamics in lymphatic tissues. Annu Rev Immunol. 17:1999;625-656.
5. Kovacs J.A., Lempicki R.A., Sidorov I.A., et al. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J Exp Med. 194:2001;1731-1741.
6. Hazenberg M.D., Stuart J.W.R.C., Otto S.A., et al. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation. Blood. 95:2000;249-255.
7. Schacker T., Little S., Connick E., et al. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis. 183:2001;555-562.
8. Hosmalinn A., Samri A., Dumaurier M.J., et al. HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. Blood. 97:2001;2695-2701.
9. Brodie S.J., Patterson B.K., Lewinsohn D.A., et al. HIV-specific cytotoxic T lymphocytes traffic to lymph nodes and localize at sites of HIV replication and cell death. J Clin Invest. 105:2000;1407-1417.
10. Chen G., Shankar P., Lange C., et al. CD8 T cells specific for human immunodefidiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to sites of infection. Blood. 98:2001;156-164.
11. Iyengar S., Schwartz D.H., Hildreth J.E.K. T cell tropic HIV gp120 mediates CD4 and CD8 cell chemotaxis through CXCR4 independent of CD4: implications for HIV pathogenesis. J Immunol. 162:1999;6263-6267.
12. Chen J.J., Huang J.C., Shirtliff M., et al. CD4 lymphocytes in the blood of HIV(+) individuals migrate rapidly to lymph nodes and bone marrow: support for homing theory of CD4 cell depletion. J Leukoc Biol. 72:2002;271-278.
13. Anthony K.B., Yoder C., Metcalf J.A., et al. Incomplete CD4 T cell recovery in HIV-1 infection after 12 months of highly active antiretroviral therapy is associated with ongoing increased CD4 T cell activation and turnover. J Aquir Immun Defic Syndr. 33:2003;125-133.
14. Hazenberg M.D., Otto S.A., Wit F.W., Lange J.M., Hamman D., Miedema F. Discordant responses during antiretroviral therapy: role of immune activation on T cell redistribution rather than true CD4 T cell loss. AIDS. 16:2002;1287-1289.
15. D'Ettore G., Forcina G., Andreotti M., et al. Discordant response to antiretroviral therapy: HIV isolation, genotypic mutations, T-cell proliferation and cytokine production. AIDS. 16:2002;1877-1885.
16. Hazenberg M., Hamann D., Schuitemaker H., Miedema F. T-cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat Immunol. 1:2000;285-289.
17. Scharko A.M., Perlman S.B., Hinds P.W. 2nd, Hanson J.M., Uno H., Pauza C.D. Whole body positron emission tomography imaging of simian immunodeficiency virus-infected rhesus macaques. Proc Natl Acad Sci USA. 93:1996;6425-6430.
18. Wallace M., Pyzalski R., Horejsh D., et al. Whole body positron emission tomography imaging of activated lymphoid tissues during acute simian-human immunodeficiency virus 89·6PD infection in rhesus macaques. Virology. 274:2000;255-261.
19. Brand K.A., Hermfisse U. Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species. FASEB J. 11:1997;388-395.
20. Bental M., Deutsch C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn Reson Med. 29:1993;317-326.
21. Marjanovic S., Skog S., Heiden T., Tribukait B., Nelson B.D. Expression of glycolytic isoenzymes in activated human peripheral lymphocytes: cell cycle analysis using flow cytometry. Exp Cell Res. 193:1991;425-431.
22. Zasadny K.R., Wahl R.L. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluorodeoxyglucose: variations with body weight and a method for correction. Radiology. 189:1993;847-850.
23. Kim C.K., Gupta N.C., Chandramouli B., Alavi A. Standardized uptake values of FDG: body surface area correction is preferable to body weight correction. J Nucl Med. 35:1994;164-167.
24. Wahl R.L., Zasadny K., Helvie M., Hutchins G.D., Weber B., Cody R. Metabolic monitoring of breast cancer chemohormonaltherapy using positron emission tomography: initial evaluation. J Clin Oncol. 11:1993;2101-2111.
25. Akhurst T., Ng V.V., Larson S.M., et al. Tumor burden assessment with positron emission tomography. Clin Positron Imaging. 3:2000;57-65.
26. Kwan A., Seltzer M., Czernin J., Chou M.J., Kao C.H. Characterization of hilar lymph node by 18F-fluor-2-deoxyglucose positron emission tomography in healthy subjects. Anticancer Res. 21:2001;701-706.
27. Yasuda S., Takahashi W., Takagi S., Fujii H., Ide M., Shohtsu A. Factors influencing physiological FDG uptake in the intestine. Tokai J Exp Clin Med. 23:1998;241-244.
28. Thomas M.B., Tronco G.G., Karayalcin G., Palestro C.J. FDG uptake in infectious mononucleosis. Clin Positron Imaging. 3:2000;176.
29. Blattman J.N., Sourdive D.J., Murali-Krishna K., Ahmed R., Altman J.D. Evolution of the T cell repertoire during primary, memory, and recall responses to viral infection. J Immunol. 165:2000;6081-6090.
30. Krzysiek R., Rudent A., Bouchet-Delbos L., et al. Preferential and persistent depletion of CCR5+ T helper lymphocytes with non-lymphoid homing potential despite early treatment of primary HIV infection. Blood. 98:2001;3169-3171.
31. Fu Y.-X., Chaplin D.D. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol. 17:1999;399-433.
32. Adams S., Baum R.P., Hertel A., et al. Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med. 39:1998;1155-1160.